BPG is committed to discovery and dissemination of knowledge
Citation
Chen P, Yu M, Zhang JL, Chen WY, Zhu L, Song Y, Jiang CY, Zhang S. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report. World J Clin Cases 2020; 8(13): 2876-2884 [PMID: 32742998 DOI: 10.12998/wjcc.v8.i13.2876]
Please LOGIN to submit a new comment.